interleukin cytokines
The blood test detects the presence of seven proteins to determine if a patient is likely to respond to the FDA-approved treatment siltuximab.
Proxim Diagnostics Developing Handheld Analyzer for Point-of-Care, SARS-CoV-2 Testing
The firm is developing a test to determine interleukin-6 levels for SARS-CoV-2 patients and a rapid antigen test.
Bluejay Diagnostics, Toray Industries Collaborate on IL-6 POC Test for SARS-CoV-2
The test quantitates IL-6 in whole blood for patients who have progressing SARS-CoV-2 symptoms and have a high risk of intubation.
Interleukin Biomarkers Could Help Determine Severity of COVID-19, According to New Study
The ratio of IL-6 to IL-10 biomarkers might give clinicians insight into how severe the inflammatory response to SARS-CoV-2 could be in certain patients.
The company plans to develop tests for prostate cancer risk assessment, prostate cancer screening, and breast cancer screening.